1. Diaphragmatic Breathing Reduces Belching and Proton Pump Inhibitor Refractory Gastroesophageal Reflux Symptoms 
Andrew Ming-Liang Ong, Laura Teng-Teng Chua, Christopher Jen-Lock Khor, Ravishankar Asokkumar, Vikneswaran s/o Namasivayam, Yu-Tien Wang 
Clinical Gastroenterology and Hepatology 
Volume 16, Issue 3, Pages e2 (March 2018)
DOI: /j.cgh
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1 Flow diagram of study. HRM = high-resolution manometry.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

3. Figure 2
(A) Gastric belch. Characterized by rise in impedance in distal rings initially and then moving proximally, reflective of retrograde gas movement. Arrows indicate direction of airflow. This belch is symptomatic, evident by patient-reported symptom marker. Impedance levels return to levels lower than baseline, suggestive of concomitant reflux episode, acidic as pH <4. (B) Supragastric belch. Characterized by rise in impedance in proximal rings initially and then moving distally. This is followed by rapid return to baseline in distal leads first and then proximally, reflective of the quick gas expulsion. Arrows indicate direction of airflow.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

4. Figure 3
(A) Mean belching VAS pre- and post-DB in treatment group.a (B) Mean belching VAS pre- and post-wait-list period in WLC. aP value of comparison of belching VAS improvements between patients in A and B < .001.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

5. Figure 4
Clinical outcomes pre-DB, post-DB, and 4 months post-DB. (A) Mean belching VAS, (B) mean RDQ, (C) mean RQS, (D) mean EuroQol VAS.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions